Sphere Medical has delivered the first order of its Proxima 3 blood gas analyser for intensive care units.
Sphere Medical makes commercial breakthrough with Proxima 3
Proxima 3 is a patient-dedicated aterial blood gas analyser that supports rapid and frequent measurement without leaving the patient’s bedside. It can reduce the time, from ordering blood gas test to receiving the results, by 40-60 per cent in a typical clinical environment as well as eliminating the time the nurse is required to spend away from the patient.
The company is continuing the commercialisation of Proxima 3 into the UK market and then into the German, Dutch and Belgium markets, with the finalisation in the development of Proxima 4. Sphere medical is developing its Proxima 4 alongside Ortho-Clinical Diagnostics.
Dr. Anthony Martin, current non-executive chairman of Sphere Medical, said: “Sphere Medical has delivered its first commercial order of Proxima 3 product, which represents an important milestone for the company. Furthermore, we are continuing to grow the number of hospitals showing interest in Proxima 3 and work is continuing with these hospitals for the sale of Proxima into their intensive care settings.
Under the terms of the collaboration agreement with Ortho-Clinical Diagnostics, Sphere Medical has granted an option to Ortho-Clinical to enter into good faith negotiations for the exclusive rights to commercialise Proxima 4.
Work is also on schedule for the submission of the technical and design dossier files necessary for the approval of Proxima 4’s CE marks. We currently expect to release these files to our notified body during Q3 2015.”